Evidence map›Paper›PMID 12165665›Full record

ArticleEndocrine pathology2002

Prolactin-producing pituitary adenoma associated with prolactin cell hyperplasia.

Sergio Vidal, Eva Horvath, Luis V Syro, Humberto Uribe, Sandy Cohen, Kalman Kovacs

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. The pituitary in klinefelter syndrome.Endocrine pathology · 2005
    Article
  3. Mechanisms for pituitary tumorigenesis: the plastic pituitary.The Journal of clinical investigation · 2003
    Review
  4. Best Practice No 172: pituitary gland pathology.Journal of clinical pathology · 2003
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Sergio VidalDepartment of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. svidal@lugo.usc.es
Eva Horvath
Luis V Syro
Humberto Uribe
Sandy Cohen
Kalman Kovacs
St. Michael's Hospital · CAHospital Pablo Tobon Uribe · COUniversidad de Antioquia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 24-yr-old woman with amenorrhea, galactorrhea, hyperprolactinemia, and sellar mass underwent transsphenoidal surgery. Histologic, immunohistochemical, and electron microscopic investigation revealed a well-differentiated, sparsely granulated prolactin (PRL) cell adenoma of the pituitary showing conclusive PRL immunoreactivity. In the nontumorous adenohypophysis PRL cell hyperplasia was noted. Marked differences were evident between the neoplastic and hyperplastic areas. The tumor consisted of sparsely granulated PRL cells immunoreactive only for PRL. As demonstrated by immunoelectron microscopy, the hyperplastic area comprised monohormonal sparsely granulated PRL cells as well as bihormonal mammosomatotrophs immunoreactive for both PRL and growth hormone. The MIB-1 index was higher whereas microvessel density was lower in the adenoma as compared with the hyperplastic area. In addition, the nontumorous area showed lymphocytic infiltration whereas inflammatory reaction was not seen in the adenoma. This case represents a rare association of a PRL cell adenoma and PRL cell hyperplasia. The fact that these two lesions were contiguous in the surgically removed material raises the possibility that hyperplasia can precede and transform into adenoma.

Indexed as

AdultBiomarkers, TumorCell DivisionFemaleHumansHyperplasiaMicroscopy, ImmunoelectronPituitary NeoplasmsProlactinomaBiomarkers, Tumor

Identifiers

PMID12165665
OpenAlexW2028961612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.